LOGIN
ID
PW
MemberShip
2025-11-01 15:58
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
Input Time : 2019-12-23
[Download file]
go back
OPINION
[Reporter¡¯s View] The dark side of flashy health campaigns
Reporter's view |
Son, Hyung Min
[Reporter¡¯s View] China¡¯s rise poses new challenges
Reporter's view |
Hwang, byoung woo
[Reporter's View] Transparent info, the key to vaccine trust
Reporter's view |
Son, Hyung Min
INTERVIEW
"GI Innovation challenges melanoma"
"...overcoming resistance to PD-1 antibodies" says Myoung Ho Jang, CEO of GI Innovation
"New landscape in DLBCL trt¡¦Columvi¡¤Polivy's bigger role"
Professor Gareth Gregory of Monash University in Australia
"Gilead-Kite will lead the trt landscape for DLBCL in KOR"
Diego Santoro, Head of the International Region for Kite Pharma
Dong-A ST launches Sterlara biosimilar Imuldosa in the US
V-olet challenges to become a blockbuster fat-destroying inj
Kim Seul-ki, PM of Daewoong Pharmaceutical's Nabota Business Team
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
HIRA ¡°Low-price drug incentive brings ₩2.7 savings'
2
Hanmi "Phase 3 trial confirms efficacy of GLP-1 drug"
3
MOHW ¡®will support pharma amid U.S. drug tariff plans¡¯
4
NHIS actively reviews unifying drug price-reduction system
5
ImmuneOncia speeds commercialization with product-fit plan
6
How did CPAC evaluate Wegovy's adolescent indication?
7
Lotte Biologics¡¤SK Pharmteco jointly target global ADC mkt
8
Ultomiris's reimb standards eased for aHUS
9
[Reporter¡¯s View] China¡¯s rise poses new challenges
10
"Severe COVID-19 cases continue to rise...infection control"